BERKELEY, Calif.–(BUSINESS WIRE)–Newomics Inc., a commercial-stage biotechnology company that sells and
develops mass spectrometry products, services and diagnostics, today
announced a co-marketing agreement with Thermo Fisher Scientific, the
world leader in serving science. The companies will engage in joint
marketing of multinozzle emitters from Newomics and liquid
chromatography (LC) and mass spectrometry (MS) systems from Thermo
Fisher.
The Newomics award-winning silicon multinozzle emitters (M3 emitters)
enable optimization of sensitivity, throughput and robustness for LC-MS
by splitting the LC eluent evenly into multiple flows at the emitter,
thereby dramatically enhancing the ionization efficiency. The first
commercially-available M3 emitter has been optimized for microflow
LC – nanospray MS and can easily be configured for the Thermo
Scientific microflow LC-MS systems and the Thermo
Scientific Nanospray Flex ion source.
“We are excited about the Co-Marketing agreement with Thermo Fisher
Scientific, a global leader in liquid chromatography and mass
spectrometry. This was built upon our close collaborations over the last
5 years with multiple Thermo teams including those in R&D and Omics
Marketing,” said Daojing Wang, Founder and CEO, Newomics. “Going
forward, we will work closely with Thermo to further optimize our joint
platform for high-throughput workflows to meet the diverse needs from
our customers.”
“The M3 emitter has the potential to be a transformative technology,”
said Ken Miller, vice president, life sciences mass spectrometry, Thermo
Fisher Scientific. “The ability to combine the robustness of microflow
LC with the sensitivity of nanospray MS should allow for the expanded
use of LC-MS in translational proteomics applications. We look forward
to expanding our collaborations with Newomics to deliver novel LC-MS
solutions to serve the high-throughput needs of our clinical research
customers.”
About Newomics
Newomics Inc. is dedicated to creating and commercializing innovative
(New) and integrative (Omics) platforms and solutions for precision
medicine. The company’s first product, the M3 multinozzle emitter for
MS, enables the robustness of microflow LC and the sensitivity of
nanospray ionization MS. The plug-and-play M3 emitters are currently
interfaced to diverse MS instruments and can be ordered at www.newomics.com.
Contacts
Steven Bodovitz
Newomics Inc.
(510) 833-2811
sbodovitz@newomics.com